DexCom, Inc. Price Today
DexCom, Inc.
DXCM
Healthcare
$46.64B
💰
Market Cap
167.1
💸
Price to Earnings
$0.7
🎉
EPS
+76
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
10 |
Strong Buy |
14 |
Hold |
4 |
Sell |
0 |
Strong Sell |
0 |
DXCM Price Forecast Target
120.3 👉 175.0 +45%
DXCM EPS Forecast
0.7 👉 1.6 +122%
Financials
Profit Margin
11 %
Revenue Growth
25.2 %
Dividend
$ 0
Held Percent
0.4% - Insiders
100.7% - Institutions
-1.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $5.3B
-
💰 Blackrock Inc. $4.0B
-
💰 Baillie Gifford and Company $2.0B
-
💰 State Street Corporation $1.9B
-
💰 Sands Capital Management, LLC $1.7B
Stock Ideas
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …📮FAQ
Some Frequently Asked Questions.
The DexCom, Inc. industry is Medical Devices
The DexCom, Inc. sector is Healthcare
The DexCom, Inc. forecasted predicted Price to Earnings PE ratio is 75.2
The DexCom, Inc. Price to Earnings PE ratio is 167.1
The Market Capitalization of DexCom, Inc. is $46.64B
There are total of 384823124 float shares with 100.7% held by Institutions and 0.4% held by insiders
The MDexCom, Inc. forecasted Earnings per Share EPS is $1.6
The DexCom, Inc. Earnings per Share EPS is 0.7
The DexCom, Inc. company has $1883100000 gross profits with 11 profit margins
The DexCom, Inc. Earnings Growth is 1.227% with 1.277% quarterly earnings growth
The DexCom, Inc. Revenue is $3197600000 with 0.252 revenue growth
The price target for DexCom, Inc. stock is $175.0 for the high target and $131.0 for the low target
The consensus analyst recommendations for DexCom, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for DexCom, Inc. is Buy, with the following breakdown:
- Buy: 10
- Strong Buy: 14
- Hold: 4
- Sell: 0
- Strong Sell: 0
The Beta of DexCom, Inc. is 1.1
The dividend of DexCom, Inc. is $0
The dividend yield of DexCom, Inc. is 0%
The biggest institutional and mutual fund holders of DexCom, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Baillie Gifford and Company
- State Street Corporation
The DexCom, Inc. ESG Score is 76, with the following breakdown:
- E: 5.39
- S: 10.24
- G: 8.08